Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Dec 23, 2021 5:45pm
231 Views
Post# 34259503

RE:Has CV19 kept the burn so loe?

RE:Has CV19 kept the burn so loe?

When data will hopefully soon conclusively place TLD-1433 as the (or one of the) top contenders as a new Gold Standard for BCG UnResponsive NMIBC, then SP may surely rise to levels never before reached.  At that time point, excercise of warrants and/or a raise would be appropriate.  We all know it's coming soon enough and the company has more than enough cash to get us there.  So long as data is consistently good in the next batch.  All IMHO 


SouthernTierTom wrote: I was estimating that there was about 3.5M CAD in the kitty...

Seems a bit of a catch 22, if trial activity ramps up s we hope....so will burn.

We had about 1.6M or so in the kitty tha last time we "raised", but we are now deep into the phase 2 experience that includes operations here in the US.

I would not at all be unhappy with a "raise"...but at what price?

Thoughts,

Tuckey?...Macer? ; - )


 

<< Previous
Bullboard Posts
Next >>